Partner network
Advanced Consensus partners with specialized molecular and genomic reference laboratories in South Korea and the United States — each selected for clinical depth, assay quality, and turnaround reliability.
Seoul, South Korea · Rare Disease & Exome Genomics
Reference laboratory
A rare-disease genomics specialist with one of the largest clinical variant databases in the field. AC routes whole exome sequencing, whole genome sequencing, and focused rare-disease panels through 3billion for pediatric, adult, and undiagnosed disease cases.
Yongin, South Korea · NGS · Oncology · Hereditary Cancer
Reference laboratory
A full-service molecular genomics laboratory offering a broad NGS portfolio across oncology, hereditary cancer, pharmacogenomics, and infectious disease. AC uses GC Genome for comprehensive solid tumor profiling, germline predisposition panels, and PGx testing.
Yongin, South Korea · Full-Service Clinical Reference Laboratory
Reference laboratory
Korea's first commercial clinical laboratory, founded in 1982 as Green Cross Bio Science Lab and independent since 1986. It is a general clinical reference laboratory and a separate organization from GC Genome, which handles AC's genomics work. GC Labs runs around 100 million tests a year across more than 5,000 test items for some 5,000 medical institutions, with roughly 800 staff including 50 physicians specialised in laboratory medicine and pathology. It is CAP-accredited and ISO 15189-compliant, and is Korea's member of the Global Diagnostics Network. AC uses GC Labs for esoteric and specialised clinical pathology that sits outside the genomics menu — mass-spectrometry endocrinology, immunology and autoimmunity, microbiology and tuberculosis, and histopathology with immunohistochemistry.
Incheon, South Korea · NIPT · Reproductive Genetics · Cytogenomics
Reference laboratory
A reproductive and prenatal genomics laboratory with deep expertise in non-invasive prenatal testing, chromosomal microarray, and preimplantation genetic testing. AC routes NIPT, CMA, and pregnancy-loss evaluation through EDGC.
Gaithersburg, Maryland, USA · Rare Disease Exome & Genome Sequencing
Reference laboratory
One of the largest rare-disease sequencing laboratories in the world, with more than 25 years in genomic medicine and over a million exomes and genomes sequenced. Its ExomeDx and GenomeDx tests hold FDA Breakthrough Device designation, and its interpretation draws on a rare-disease dataset behind more than 1,100 peer-reviewed studies. AC routes exome and genome sequencing through GeneDx where the case calls for the largest available phenotype-linked variant evidence base — particularly paediatric neurodevelopmental, epilepsy, and congenital anomaly cases, and time-critical NICU and PICU sequencing.
All accreditations, certifications, and quality standards listed or implied on this page are held by the respective partner organizations — not by Advanced Consensus. AC is a diagnostics coordination company, not a testing laboratory. We do not perform genetic or molecular testing in-house.
Partner names and logos are the property of their respective owners and are shown here to identify the laboratories and manufacturers AC works with.
Our role is to match the clinical question to the appropriate testing pathway, coordinate sample logistics, and ensure the report reaches the ordering physician in a clinically useful format. Specific accreditation documentation for each partner is available on request.
Work with us
Suite 403, 133 Madina Munawara St, Amman, Jordan
+962 791 707 606 info@advancedconsensus.comMessage us on WhatsAppFor website inquiries, do not include patient names, medical record numbers (MRNs), national IDs, dates of birth, or identifiable reports or documents. Secure document exchange should happen through approved clinical channels.
